It remains an investigational compound available only through clinical trial participation
GLP-1RAs are generally recommended for patients with T2D whose glycated haemoglobin (HbA 1c ) is above target despite diet, exercise and existing glucose-lowering medication, and GLP-1RAs with proven cardiovascular benefit are also recommended in patients with T2D at elevated cardiovascular risk, regardless of HbA 1c [5, 6]
For those struggling to find food that sits well, feels good, and hits those macro goals, we have done the heavy lifting for you
Many people experience noticeable appetite reduction and steady weight loss when using Wegovy under doctor supervision
The tirzepatide expiration guide explains why visual assessment alone is insufficient
This marked a significant step forward in diabetes treatment